Gut microbiota and thyroid diseases – summary of current knowledge
DOI:
https://doi.org/10.12775/QS.2024.16.52770Keywords
microbiota, thyroid diseases, thyroiditis, Hashimoto disease, thyroid neoplasms, Graves diseaseAbstract
Introduction and purpose: The gut microbiota is a diverse collection of microorganisms that coexist in the human intestine. Disorders in its structure leads to dysregulation of huge number of organs, including the thyroid. This review summarizes the latest findings regarding the links between gut microbiota and common thyroid diseases: Hashimoto's thyroiditis, Graves' disease and thyroid cancer.
Materials and methods: This review was based on the PubMed and Google Scholar databases, using keywords: „gut microbiota AND thyroid/Hashimoto/Graves/thyroid cancer”, „Graves’ disease”, ,,Hashimoto thyroiditis”.
Description of knowledge: Gut dysbiosis can contribute to autoimmune thyroid diseases by influencing micronutrient availability and immune regulation. Specific bacterial species may impact Hashimoto's development by regulating neurotransmitters and hormone secretion. In Graves' disease, significant changes in gut microbiota suggest their potential role in autoimmune processes. Research on gut microbiota in thyroid cancer suggests potential diagnostic tools and implicates gut microbiota alterations in tumor development.
Conclusions: Significant gut microbiota changes are observed in Hashimoto's thyroiditis, Graves' disease, and thyroid cancer compared to healthy individuals, indicating a possible association. However, the exact mechanisms remain unclear, necessitating further research to understand how microbiota alterations contribute to these diseases.
References
Adak A, Khan MR. An insight into gut microbiota and its functionalities. Cell Mol Life Sci. 2019;76(3):473-493. doi:10.1007/s00018-018-2943-4
Knezevic J, Starchl C, Berisha AT, Amrein K. Thyroid-Gut-Axis: How Does the Microbiota Influence Thyroid Function? Nutrients. 2020;12(6):1-16. doi:10.3390/NU12061769
Yu X, Jiang W, Kosik RO, et al. Gut microbiota changes and its potential relations with thyroid carcinoma. J Adv Res. 2021;35:61-70. doi:10.1016/J.JARE.2021.04.001
Laha D, Nilubol N, Boufraqech M. New Therapies for Advanced Thyroid Cancer. Front Endocrinol (Lausanne). 2020;11:82. doi:10.3389/FENDO.2020.00082
Jiang W, Lu G, Gao D, Lv Z, Li D. The relationships between the gut microbiota and its metabolites with thyroid diseases. Front Endocrinol (Lausanne). 2022;13: 943408. doi:10.3389/FENDO.2022.943408
Fröhlich E, Wahl R. Thyroid Autoimmunity: Role of Anti-thyroid Antibodies in Thyroid and Extra-Thyroidal Diseases. Front Immunol. 2017;8:521. doi:10.3389/FIMMU.2017.00521
Fenneman AC, Rampanelli E, Van Der Spek AH, Fliers E, Nieuwdorp M. Protocol for a double-blinded randomised controlled trial to assess the effect of faecal microbiota transplantations on thyroid reserve in patients with subclinical autoimmune hypothyroidism in the Netherlands: the IMITHOT trial. BMJ Open. 2023;13(9):e073971. doi:10.1136/BMJOPEN-2023-073971
Ralli M, Angeletti D, Fiore M, et al. Hashimoto’s thyroiditis: An update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation. Autoimmun Rev. 2020;19(10):102649. doi:10.1016/j.autrev.2020.102649
Waliszewska-Prosół M, Ejma M. Hashimoto Encephalopathy-Still More Questions than Answers. Cells. 2022;11(18):2873. doi:10.3390/cells11182873
Cayres LC de F, de Salis LVV, Rodrigues GSP, et al. Detection of Alterations in the Gut Microbiota and Intestinal Permeability in Patients With Hashimoto Thyroiditis. Front Immunol. 2021;12:579140. doi:10.3389/FIMMU.2021.579140/BIBTEX
Fröhlich E, Wahl R. Microbiota and Thyroid Interaction in Health and Disease. Trends Endocrinol Metab. 2019;30(8):479-490. doi:10.1016/J.TEM.2019.05.008
Song Y, Zhao M, Zhang H, et al. THYROID-STIMULATING HORMONE LEVELS ARE INVERSELY ASSOCIATED WITH SERUM TOTAL BILE ACID LEVELS: A CROSS-SECTIONAL STUDY. Endocr Pract. 2016;22(4):420-426. doi:10.4158/EP15844.OR
MEANS JH, LITTLEFIELD J. Graves’ disease. Am Pract Dig Treat. 1948;2(7):488-493.
Liu J, Qin X, Lin B, et al. Analysis of gut microbiota diversity in Hashimoto’s thyroiditis patients. BMC Microbiol. 2022;22(1):318. doi:10.1186/S12866-022-02739-Z
Ishaq HM, Mohammad IS, Guo H, et al. Molecular estimation of alteration in intestinal microbial composition in Hashimoto’s thyroiditis patients. Biomed Pharmacother. 2017;95:865-874. doi:10.1016/J.BIOPHA.2017.08.101
Lane LC, Wood CL, Cheetham T. Graves’ disease: moving forwards. Arch Dis Child. 2023;108(4):276-281. doi:10.1136/ARCHDISCHILD-2022-323905
Davies TF, Schwartz AE. Hyperthyroidism. Ann Intern Med. 2020;172(7):101-114. doi:10.7326/AITC202004070
Masetti G, Ludgate M. Microbiome and Graves’ Orbitopathy. Eur Thyroid J. 2020;9(Suppl 1):78-86. doi:10.1159/000512255
Ishaq HM, Mohammad IS, Shahzad M, et al. Molecular Alteration Analysis of Human Gut Microbial Composition in Graves’ disease Patients. Int J Biol Sci. 2018;14(11):1558-1570. doi:10.7150/IJBS.24151
Chen J, Wang W, Guo Z, et al. Associations between gut microbiota and thyroidal function status in Chinese patients with Graves’ disease. J Endocrinol Invest. 2021;44(9):1913-1926. doi:10.1007/S40618-021-01507-6
Jiang W, Yu X, Kosik RO, et al. Gut Microbiota May Play a Significant Role in the Pathogenesis of Graves’ Disease. Thyroid. 2021;31(5):810-820. doi:10.1089/THY.2020.0193
Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17-48. doi:10.3322/CAAC.21763
Vaccarella S, Dal Maso L. Challenges in investigating risk factors for thyroid cancer. Lancet Diabetes Endocrinol. 2021;9(2):57-59. doi:10.1016/S2213-8587(20)30426-5
Reiners C, Drozd V. Editorial: Radiation as Risk Factor, Early Diagnosis, Therapy, and Follow-up of Differentiated Thyroid Cancer. Front Endocrinol (Lausanne). 2021;12:797969. doi:10.3389/FENDO.2021.797969
Drozd V, Saenko V, Branovan DI, Brown K, Yamashita S, Reiners C. A Search for Causes of Rising Incidence of Differentiated Thyroid Cancer in Children and Adolescents after Chernobyl and Fukushima: Comparison of the Clinical Features and Their Relevance for Treatment and Prognosis. Int J Environ Res Public Health. 2021;18(7):3444. doi:10.3390/IJERPH18073444
Zhou J, Zhang X, Xie Z, Li Z. Exploring reciprocal causation: bidirectional mendelian randomization study of gut microbiota composition and thyroid cancer. J Cancer Res Clin Oncol. 2024;150(2):75. doi:10.1007/S00432-023-05535-Y
Sun X, Chen S, Zhao S, Wang J, Cheng H. Causal relationship of genetically predicted gut microbiota with thyroid cancer: a bidirectional two-sample mendelian randomization study. Front Endocrinol (Lausanne). 2024;15:1284472. doi:10.3389/FENDO.2024.1284472
Feng J, Zhao F, Sun J, et al. Alterations in the gut microbiota and metabolite profiles of thyroid carcinoma patients. Int J Cancer. 2019;144(11):2728-2745. doi:10.1002/IJC.32007
Shin NR, Whon TW, Bae JW. Proteobacteria: microbial signature of dysbiosis in gut microbiota. Trends Biotechnol. 2015;33(9):496-503. doi:10.1016/J.TIBTECH.2015.06.011
Stojanov S, Berlec A, Štrukelj B. The Influence of Probiotics on the Firmicutes/Bacteroidetes Ratio in the Treatment of Obesity and Inflammatory Bowel disease. Microorganisms. 2020;8(11):1715. doi:10.3390/MICROORGANISMS8111715
Feng Q, Liang S, Jia H, et al. Gut microbiome development along the colorectal adenoma-carcinoma sequence. Nat Commun. 2015;6:6528. doi:10.1038/NCOMMS7528
Fuhrman BJ, Feigelson HS, Flores R, et al. Associations of the fecal microbiome with urinary estrogens and estrogen metabolites in postmenopausal women. J Clin Endocrinol Metab. 2014;99(12):4632-4640. doi:10.1210/JC.2014-2222
van der Beek CM, Dejong CHC, Troost FJ, Masclee AAM, Lenaerts K. Role of short-chain fatty acids in colonic inflammation, carcinogenesis, and mucosal protection and healing. Nutr Rev. 2017;75(4):286-305. doi:10.1093/NUTRIT/NUW067
Benevides L, Burman S, Martin R, et al. New Insights into the Diversity of the Genus Faecalibacterium. Front Microbiol. 2017;8:1790. doi:10.3389/FMICB.2017.01790
Ishaq HM, Mohammad IS, Hussain R, et al. Gut-Thyroid axis: How gut microbial dysbiosis associated with euthyroid thyroid cancer. J Cancer. 2022;13(6):2014-2028. doi:10.7150/JCA.66816
Zhang J, Zhang F, Zhao C, et al. Dysbiosis of the gut microbiome is associated with thyroid cancer and thyroid nodules and correlated with clinical index of thyroid function. Endocrine. 2019;64(3):564-574. doi:10.1007/S12020-018-1831-X
Gálvez EJC, Iljazovic A, Amend L, et al. Distinct Polysaccharide Utilization Determines Interspecies Competition between Intestinal Prevotella spp. Cell Host Microbe. 2020;28(6):838-852.e6. doi:10.1016/J.CHOM.2020.09.012
Dahmus JD, Kotler DL, Kastenberg DM, Kistler CA. The gut microbiome and colorectal cancer: a review of bacterial pathogenesis. J Gastrointest Oncol. 2018;9(4):769-777. doi:10.21037/JGO.2018.04.07
Trapani KM, Boghossian LJ, Caskey E. Clostridium subterminale Septicemia in a Patient with Metastatic Gastrointestinal Adenocarcinoma. Case Rep Infect Dis. 2018;2018:6031510. doi:10.1155/2018/6031510
Benitez AJ, Hoffmann C, Muir AB, et al. Inflammation-associated microbiota in pediatric eosinophilic esophagitis. Microbiome. 2015;3:23. doi:10.1186/S40168-015-0085-6
Memba R, Duggan SN, Ni Chonchubhair HM, et al. The potential role of gut microbiota in pancreatic disease: A systematic review. Pancreatology. 2017;17(6):867-874. doi:10.1016/J.PAN.2017.09.002
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Aleksander Daniluk, Kaja Iwaniuk, Martyna Wojda, Magdalena Świstowska, Aleksandra Wielgosz
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 234
Number of citations: 0
